Eli Lilly partners with BioArctic AB to combine drug delivery tech with its neurodegeneration drugSee details
Eli Lilly - LLY - stock price prediction, stock price target, analyst ratings from 31 analysts
Eli Lilly has a share price target of US$ 1219, revenue growth forecast of 30.8%, and profit growth estimate of 50.1% for FY26, based on top 31 analyst calls.